Viewing Study NCT01018368


Ignite Creation Date: 2025-12-24 @ 5:54 PM
Ignite Modification Date: 2025-12-28 @ 4:07 AM
Study NCT ID: NCT01018368
Status: COMPLETED
Last Update Posted: 2010-05-10
First Post: 2009-11-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of VX-770 and Rifampin in Healthy Male Subjects
Sponsor: Vertex Pharmaceuticals Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module